Tetrahydrocannabinol (THC) and Sleep

EARLY_PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

September 19, 2021

Study Completion Date

April 30, 2025

Conditions

SleepTHCMarijuanaCannabis

Interventions

DRUG

Dronabinol

Single dose oral administration of 10-60mg dronabinol prior to night 2 or 3 sleep in the clinical laboratory.

Trial Locations (1)

Oregon Health & Science University, Portland

All Listed Sponsors

lead

Oregon Health and Science University

OTHER